Hyperlactataemia syndromes associated with HIV therapy

This publication has 89 references indexed in Scilit:

• Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors
  AIDS, 2002
• Hyperlactatemia syndromes in people with HIV infection
  Current Opinion in Infectious Diseases, 2002
• Hyperlactatemia and Antiretroviral Therapy: The Swiss HIV Cohort Study
  Clinical Infectious Diseases, 2001
• Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy
  AIDS, 2001
• Management of hyperlactatemia: no need for routine lactate measurements
  AIDS, 2001
• Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy
  AIDS, 2000
• Editorial Response: Hyperlactatemia and Hepatic Steatosis as Features of Mitochondrial Toxicity of Nucleoside Analogue Reverse Transcriptase Inhibitors
  Clinical Infectious Diseases, 2000
• Azidothymidine triphosphate is an inhibitor of both human immunodeficiency virus type 1 reverse transcriptase and DNA polymerase gamma
  Antimicrobial Agents and Chemotherapy, 1989
• Comparison of the effect of Carbovir, AZT, and dideoxynucleoside triphosphates on the activity of human immunodeficiency virus reverse transcriptase and selected human polymerases
  Biochemical and Biophysical Research Communications, 1989
• Studies on the inhibition of mitochondrial DNA replication by 3′-azido-3′-dhoxythymidine and other dideoxynucleoside analogs which inhibit HIV-1 replication
  Biochemical Pharmacology, 1989